Pathstone Holdings LLC Raises Holdings in Omega Healthcare Investors, Inc. (NYSE:OHI)

Pathstone Holdings LLC increased its position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 23.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 32,112 shares of the real estate investment trust’s stock after buying an additional 6,199 shares during the period. Pathstone Holdings LLC’s holdings in Omega Healthcare Investors were worth $1,307,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in OHI. Lazard Asset Management LLC increased its position in Omega Healthcare Investors by 259.1% during the 1st quarter. Lazard Asset Management LLC now owns 4,043 shares of the real estate investment trust’s stock valued at $128,000 after purchasing an additional 2,917 shares during the period. Price T Rowe Associates Inc. MD raised its stake in Omega Healthcare Investors by 2.7% in the first quarter. Price T Rowe Associates Inc. MD now owns 133,166 shares of the real estate investment trust’s stock worth $4,218,000 after buying an additional 3,466 shares in the last quarter. Bayesian Capital Management LP purchased a new stake in Omega Healthcare Investors during the first quarter worth $329,000. Tidal Investments LLC boosted its position in Omega Healthcare Investors by 2.5% during the 1st quarter. Tidal Investments LLC now owns 14,325 shares of the real estate investment trust’s stock valued at $454,000 after acquiring an additional 348 shares in the last quarter. Finally, Cetera Investment Advisers increased its holdings in shares of Omega Healthcare Investors by 170.6% in the 1st quarter. Cetera Investment Advisers now owns 97,866 shares of the real estate investment trust’s stock valued at $3,099,000 after acquiring an additional 61,700 shares during the period. 65.25% of the stock is currently owned by institutional investors.

Omega Healthcare Investors Stock Performance

Shares of OHI stock opened at $40.67 on Friday. The company has a debt-to-equity ratio of 1.10, a current ratio of 6.48 and a quick ratio of 6.48. The business has a fifty day moving average of $40.61 and a 200 day moving average of $37.24. The firm has a market capitalization of $10.98 billion, a price-to-earnings ratio of 29.90, a price-to-earnings-growth ratio of 1.25 and a beta of 0.99. Omega Healthcare Investors, Inc. has a 1 year low of $27.53 and a 1 year high of $44.42.

Omega Healthcare Investors Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were issued a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.59%. The ex-dividend date was Monday, November 4th. Omega Healthcare Investors’s dividend payout ratio (DPR) is 197.06%.

Insider Activity at Omega Healthcare Investors

In other Omega Healthcare Investors news, COO Daniel J. Booth sold 56,725 shares of the company’s stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the sale, the chief operating officer now directly owns 100,000 shares of the company’s stock, valued at approximately $4,025,000. This represents a 36.19 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the sale, the chief financial officer now directly owns 183,076 shares in the company, valued at $7,357,824.44. This represents a 10.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on OHI shares. Wells Fargo & Company reaffirmed an “overweight” rating and set a $43.00 price objective (up previously from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. Truist Financial lifted their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a research report on Wednesday, September 4th. BMO Capital Markets increased their target price on shares of Omega Healthcare Investors from $44.00 to $45.00 and gave the company a “market perform” rating in a research report on Monday, October 7th. Royal Bank of Canada lifted their price target on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a “sector perform” rating in a report on Monday, November 11th. Finally, BNP Paribas raised Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price target on the stock in a research report on Thursday, October 31st. Seven analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $40.00.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.